4/A//SEC Filing
Dobak John 4/A
Accession 0001209191-23-023658
CIK 0001651944other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:08 PM ET
Size
7.5 KB
Accession
0001209191-23-023658
Insider Transaction Report
Form 4/AAmended
DermTech, Inc.DMTK
Dobak John
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-03-09+56,407→ 700,252 total - Sale
Common Stock
2023-03-13$3.26/sh−1,559$5,082→ 698,693 total
Footnotes (2)
- [F1]Footnote No. 1 in the Form 4 originally filed on March 13, 2023 contained an error regarding the vesting schedule of the restricted stock units awarded to the reporting person. Footnote No. 1 is hereby corrected as follows: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan and the terms of a Transition Agreement, dated March 1, 2023, between the reporting person and the issuer. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) one-third (1/3) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining two-thirds (2/3) shall vest in two (2) equal installments of one-third (1/3) on the fifth day of each third month following June 5, 2023 until the final vesting date on December 5, 2023.
- [F2]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.
Documents
Issuer
DermTech, Inc.
CIK 0001651944
Entity typeother
Related Parties
1- filerCIK 0001787176
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 8:08 PM ET
- Size
- 7.5 KB